Trial reportEuropean journal of nuclear medicine and molecular imaging2022
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
Trial report in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging
The Application of Molecular Probe Targeting Fibroblast Activation Protein in Malignant Tumor of Digestive System
[68Ga]Ga-FAPI PET/CT: The Dagnostic Accuracy for Primary Staging and Re-staging After Chemotherapy in Patients With Gastric and Gastro-esophageal Junctional Cancer
[68Ga]Ga-FAPI-46 PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients With Ovarian Cancer
Who cites it
14 citing papers in PubMed, 26 citations in OpenAlex.
- Survival benefit of ⁶⁸Ga-FAPI PET/CT staging for prognostic assessment in gastric and colorectal cancer compared with CE-CT and ¹⁸F-FDG PET/CT: a single-center retrospective study.European journal of nuclear medicine and molecular imaging · 2026Article
- Gallium-Containing Agents for Tumor Diagnosis and Therapy: Current Status and Future Prospects.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- [Abdominal radiology (New York) · 2026Article
- The impact of FAPI PET on staging and management in patients with digestive system tumors: a systematic review and meta-analysis.Quantitative imaging in medicine and surgery · 2026Article
- Benign and malignant uptake in the postoperative diagnosis of gastrointestinal tumors: a comparative study ofQuantitative imaging in medicine and surgery · 2025Article
- Prognostic value of [European journal of nuclear medicine and molecular imaging · 2025Article
- Impact ofJournal of cancer research and clinical oncology · 2025Article
- Head-to-head comparison of [Translational cancer research · 2024Article
- From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.Cellular oncology (Dordrecht, Netherlands) · 2024Review
- Case report: diagnosis and treatment of advanced high-grade serous ovarian carcinoma aided byAmerican journal of nuclear medicine and molecular imaging · 2024Article
- Article
- Assessment of pulmonary fibrosis induced by paraquat using AlInternal and emergency medicine · 2023Article
- FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Review
- FAPI PET/CT in Diagnostic and Treatment Management of Colorectal Cancer: Review of Current Research Status.Journal of clinical medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGallium-68-labeled fibroblast activation protein inhibitor (
methodsPatients with malignancies were prospectively enrolled in a clinical trial to evaluate the diagnostic value of
resultsThe diagnostic accuracy of
conclusions
trial registrationNCT04554719. Registered September 8, 2020-retrospectively registered, http://clinicaltrails.gov/show/NCT04554719.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.